79 related articles for article (PubMed ID: 3043455)
1. The therapeutic use of I-131 meta-iodobenzylguanidine (mIBG) in neuroblastoma: a phase II study in 12 patients.
Hartmann O; Lumbroso JD; Lemerle M; Schlumberger M; Ricard M; Aubert B; Coornaert S; Merlin L; Parmentier C
Prog Clin Biol Res; 1988; 271():655-67. PubMed ID: 3043455
[No Abstract] [Full Text] [Related]
2. Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
Prog Clin Biol Res; 1991; 366():455-61. PubMed ID: 2068160
[No Abstract] [Full Text] [Related]
3. Iodine-125-MIBG therapy for neuroblastoma.
Hoefnagel CA; Smets L; Voûte PA; de Kraku J
J Nucl Med; 1991 Feb; 32(2):361-2. PubMed ID: 1992043
[No Abstract] [Full Text] [Related]
4. Side effects of treatment with I-131-meta-iodobenzylguanidine (I-131-MIBG) in neuroblastoma patients.
Voûte PA; Hoefnagel CA; de Kraker J; Majoor M
Prog Clin Biol Res; 1988; 271():679-87. PubMed ID: 3406024
[No Abstract] [Full Text] [Related]
5. A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.
Rutgers M; Gubbels AA; Hoefnagel CA; Voûte PA; Smets LA
Prog Clin Biol Res; 1991; 366():471-8. PubMed ID: 2068162
[No Abstract] [Full Text] [Related]
6. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
Guerra P
Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric models and S factors for radiation doses to the bladder wall in children receiving therapeutic iodine-131-MIBG.
Bolster AA; Hilditch TE; Wheldon TE
J Nucl Med; 1995 Aug; 36(8):1530-1. PubMed ID: 7629603
[No Abstract] [Full Text] [Related]
8. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
[TBL] [Abstract][Full Text] [Related]
9. [131I]MIBG as a first line treatment in advanced neuroblastoma.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
[TBL] [Abstract][Full Text] [Related]
10. Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
Klingebiel T; Bruchelt G; Kaleva N; Wollmann H; Handgretinger R; Treuner J; Gupta D; Niethammer D
Prog Clin Biol Res; 1991; 366():509-12. PubMed ID: 2068167
[No Abstract] [Full Text] [Related]
11. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
12. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
13. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
[TBL] [Abstract][Full Text] [Related]
14. MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group.
Treuner J; Gerein V; Klingebiel T; Schwabe D; Feine U; Happ J; Niethammer D; Maul F; Dopfer R; Kornhuber B
Prog Clin Biol Res; 1988; 271():669-78. PubMed ID: 3406023
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the biodistribution of meta-iodobenzylguanidine (mIBG) and the monoclonal antibody UJ13A in patients and animal models.
Lashford LS; Clarke J; Gordon I; Pritchard J; Kemshead JT
Prog Clin Biol Res; 1988; 271():643-54. PubMed ID: 3136461
[No Abstract] [Full Text] [Related]
16. A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG).
Lewis IJ; Lashford LS; Fielding S; Flower MA; Ackery D; Kemshead J
Prog Clin Biol Res; 1991; 366():463-9. PubMed ID: 2068161
[No Abstract] [Full Text] [Related]
17. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
18. Problem with mouse neuroblastoma for iodine-131 MIBG studies.
Aboul-Enein HY
J Nucl Med; 1987 Feb; 28(2):255-6. PubMed ID: 3806232
[No Abstract] [Full Text] [Related]
19. Therapeutic use of 131I-metaiodobenzylguanidine (MIBG) in neuroblastoma: a phase II study in nine patients.
Hartmann O; Lumbroso J; Lemerle J; Schlumberger M; Ricard M; Aubert B; Coonaert S; Merline L; Olive D; De Lumley L
Med Pediatr Oncol; 1987; 15(4):205-11. PubMed ID: 3657709
[TBL] [Abstract][Full Text] [Related]
20. Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of [131I-m]IBG.
Klingebiel T; Handgretinger R; Herter M; Lang P; Dopfer R; Scheel-Walter H; Niethammer D
Prog Clin Biol Res; 1994; 385():309-17. PubMed ID: 7972226
[No Abstract] [Full Text] [Related]
[Next] [New Search]